Your browser doesn't support javascript.
loading
Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448.
Cohen, Paul A; Powell, Aime; Böhm, Steffen; Gilks, C Blake; Stewart, Colin J R; Meniawy, Tarek M; Bulsara, Max; Avril, Stefanie; Brockbank, Eleanor C; Bosse, Tjalling; de Azevedo Focchi, Gustavo Rubino; Ganesan, Raji; Glasspool, Rosalind M; Howitt, Brooke E; Kim, Hyun-Soo; Lee, Jung-Yun; Le, Nhu D; Lockley, Michelle; Manchanda, Ranjit; Mandalia, Trupti; McCluggage, W Glenn; McNeish, Iain; Midha, Divya; Srinivasan, Radhika; Tan, Yun Yi; van der Griend, Rachael; Yunokawa, Mayu; Zannoni, Gian F; Singh, Naveena.
Afiliação
  • Cohen PA; Department of Gynaecological Oncology, Bendat Family Comprehensive Cancer Centre, St John of God, 12 Salvado Rd, Subiaco, Western Australia 6008, Australia; Division of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Western Australia, 35 Stirling Highway, Crawley,
  • Powell A; Division of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Western Australia, 35 Stirling Highway, Crawley,Western Australia 6009, Australia; Institute for Health Research, The University of Notre Dame Australia, 32 Mouat Street, Fremantle, Western Australia 6160,
  • Böhm S; Department of Medical Oncology, Barts Health NHS Trust,West Smithfield, London EC1A 7BE, United Kingdom.
  • Gilks CB; Department of Anatomic Pathology, Vancouver General Hospital, 899 W 12th Ave, Vancouver, BC V5Z 1M9, Canada.
  • Stewart CJR; Department of Histopathology, King Edward Memorial Hospital, 374 Bagot Road, Subiaco, Western Australia 6008, Australia.
  • Meniawy TM; School of Medicine and Pharmacology, The University ofWestern Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Gairdner Drive, Nedlands, Western Australia 6010, Australia.
  • Bulsara M; Institute for Health Research, The University of Notre Dame Australia, 32 Mouat Street, Fremantle, Western Australia 6160, Australia.
  • Avril S; Department of Pathology, School ofMedicine, CaseWestern Reserve University, University Hospitals ClevelandMedical Center and Case Comprehensive Cancer Center,Wolstein Research Building, Room 6524, 2103 Cornell Road, Cleveland, OH 44106, United States; Institute of Pathology, Technische Universität M
  • Brockbank EC; Department of Gynaecological Oncology, Barts Health NHS Trust, Whitechapel Rd, London E1 1BB, United Kingdom.
  • Bosse T; l Department of Pathology, Leiden University Medical Centre, Albinusdreef 2, PO Box 9600, 2333, ZA, Leiden, The Netherlands.
  • de Azevedo Focchi GR; Department of Pathology, Federal University de São Paulo (UNIFESP), R Botucatu, 740, São Paulo, SP CEP 04023-062, Brazil.
  • Ganesan R; Department of Cellular Pathology, Birmingham Women's NHS Foundation Trust, Mindelsohn Way, Birmingham B15 2TG, United Kingdom.
  • Glasspool RM; Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, University of Glasgow, 1053 Great Western Road, Glasgow G12 0YN, United Kingdom.
  • Howitt BE; Department of Pathology, School of Medicine, Stanford University, 300 Pasteur Drive, H2128E, Stanford, CA 94305, United States.
  • Kim HS; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
  • Lee JY; Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
  • Le ND; Cancer Control Research, British Columbia Cancer Research Centre, 675West 10th Ave, Vancouver, BC V5Z1L3, Canada.
  • Lockley M; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom; University College London Hospital, 235 Euston Rd, Fitzrovia, London NW1 2BU, United Kingdom.
  • Manchanda R; Department of Gynaecological Oncology, Barts Health NHS Trust, Royal London Hospital, 10th Floor, South Block, Whitechapel Road, London E1 1BB, United Kingdom.
  • Mandalia T; Department of Histopathology, Royal Devon and Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital (Wonford), Old Pathology Building, Church Lane, Exeter, Devon EX2 5AD, United Kingdom.
  • McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Grosvenor Road, Belfast BT12 6BA, United Kingdom.
  • McNeish I; Division of Cancer, Department of Surgery and Cancer, Imperial College London, IRDB Building, Hammersmith Hospital, London W12 0NN, United Kingdom.
  • Midha D; Department of Pathology, Tata Medical Center, Kolkata, 14 MAR, Rajarhat, Kolkata 700160, India.
  • Srinivasan R; Department of Cytology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India.
  • Tan YY; Department of Medical Oncology, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow G12 0YN, United Kingdom.
  • van der Griend R; Department of Anatomical Pathology, Canterbury Health Laboratories, 2 Riccarton Ave, Christchurch 8011, New Zealand.
  • Yunokawa M; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
  • Zannoni GF; Department of Pathology, Women and Child Health, Fondazione Policlinico Gemelli, Università Cattolica del Sacro Cuore, Largo F Vito 1, 00168 Roma, Italy.
  • Singh N; Department of Cellular Pathology, Barts Health NHS Trust, Whitechapel Rd, London E1 1BB, United Kingdom.
Gynecol Oncol ; 161(1): 328-329, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33551198

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Revista: Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Revista: Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article